Loading…

Bone Mineral Density and First Line Imaging with 18Ffluorocholine PET/CT in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism: Results from a Single Center

Objectives: Primary hyperparathyroidism (PHPT) is associated with normal or elevated calcium levels and affects bone mineral density. The proportion of cases predisposed to metabolic bone disease is unknown in patients with PHPT. The aim of this study was to assess bone mineral density and bone qual...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostics (Basel) 2024-11, Vol.14 (22)
Main Authors: Schaffler-Schaden, Dagmar, Schweighofer-Zwink, Gregor, Hehenwarter, Lukas, van der Zee-Neuen, Antje, Flamm, Maria, Beheshti, Mohsen, Pirich, Christian
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 22
container_start_page
container_title Diagnostics (Basel)
container_volume 14
creator Schaffler-Schaden, Dagmar
Schweighofer-Zwink, Gregor
Hehenwarter, Lukas
van der Zee-Neuen, Antje
Flamm, Maria
Beheshti, Mohsen
Pirich, Christian
description Objectives: Primary hyperparathyroidism (PHPT) is associated with normal or elevated calcium levels and affects bone mineral density. The proportion of cases predisposed to metabolic bone disease is unknown in patients with PHPT. The aim of this study was to assess bone mineral density and bone quality in patients with normo- or hypercalcemic primary hyperparathyroidism undergoing baseline parathyroid gland assessment with [18F]fluorocholine PET/CT imaging. Methods: A total of 140 consecutive patients were enrolled in this observational study. All patients with normo- or hypercalcemic primary hyperparathyroidism underwent dual-energy X-ray absorptiometry (DXA) for assessment of bone mineral density (BMD) and trabecular bone score (TBS). [18F]fluorocholine PET/CT was performed in all patients for the detection and localization of parathyroid adenoma. Hyper- and normocalcemic patients were compared with regard to the proportion of osteoporosis and osteopenia, T-Score, TBS, serum calcium, phosphorus and parathyroid hormone levels, the maximum standardized uptake value (SUVmax) in PET/CT imaging, and laboratory results. Results: The majority of patients was female (88.57%) and had a pathologic bone mineral density (52.86%). Overall, 33 patients had osteoporosis and 41 osteopenia. The mean lumbar T-Score was -1.48 (SD 1.37) and the T-Score of the femoral neck was -1.21 (SD 0.92). Mean TBS was also decreased (-2.13). No difference was found between normo- or hypercalcemic patients regarding bone metabolism and imaging parameters. Conclusions: More than half of patients with normo- or hypercalcemic PHPT showed abnormal BMD. First-line [18F]fluorocholine PET/CT identified parathyroid adenoma in a high proportion of patients, even in patients with normocalcemic PHPT. The early evaluation of metabolic bone disease seems desirable in clinical management of females with PHPT.Objectives: Primary hyperparathyroidism (PHPT) is associated with normal or elevated calcium levels and affects bone mineral density. The proportion of cases predisposed to metabolic bone disease is unknown in patients with PHPT. The aim of this study was to assess bone mineral density and bone quality in patients with normo- or hypercalcemic primary hyperparathyroidism undergoing baseline parathyroid gland assessment with [18F]fluorocholine PET/CT imaging. Methods: A total of 140 consecutive patients were enrolled in this observational study. All patients with normo- or hypercalcemic primary hype
doi_str_mv 10.3390/diagnostics14222466
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_3133414461</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3133414461</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_31334144613</originalsourceid><addsrcrecordid>eNqVTU1Lw0AUXETBov0FXt7RS202u62pR2tDBZWiuZcleW2e7Efdt0Hyg_yfrR-IV-cyw8wwI8SFzK6UmmXjhszWB05Us9R5nuvp9EgM8ux6MtJaFsd_9KkYMr9mB8ykKvLJQHzcBo_wSB6jsXCHnin1YHwDJUVO8HBI4N6ZLfktvFNqQRblxnYhhroN9jNdLarxvALy8BSiC7WxNTqqv0aW_Q7jr7OK5Ezsv92diSa1fQzUELsbeEbubGLYxODAwMvh0CLM0SeM5-JkYyzj8IfPxGW5qObL0S6Gtw45rR1xjdYaj6HjtZJKaan1VKp_VPcH92tR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3133414461</pqid></control><display><type>article</type><title>Bone Mineral Density and First Line Imaging with 18Ffluorocholine PET/CT in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism: Results from a Single Center</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Schaffler-Schaden, Dagmar ; Schweighofer-Zwink, Gregor ; Hehenwarter, Lukas ; van der Zee-Neuen, Antje ; Flamm, Maria ; Beheshti, Mohsen ; Pirich, Christian</creator><creatorcontrib>Schaffler-Schaden, Dagmar ; Schweighofer-Zwink, Gregor ; Hehenwarter, Lukas ; van der Zee-Neuen, Antje ; Flamm, Maria ; Beheshti, Mohsen ; Pirich, Christian</creatorcontrib><description>Objectives: Primary hyperparathyroidism (PHPT) is associated with normal or elevated calcium levels and affects bone mineral density. The proportion of cases predisposed to metabolic bone disease is unknown in patients with PHPT. The aim of this study was to assess bone mineral density and bone quality in patients with normo- or hypercalcemic primary hyperparathyroidism undergoing baseline parathyroid gland assessment with [18F]fluorocholine PET/CT imaging. Methods: A total of 140 consecutive patients were enrolled in this observational study. All patients with normo- or hypercalcemic primary hyperparathyroidism underwent dual-energy X-ray absorptiometry (DXA) for assessment of bone mineral density (BMD) and trabecular bone score (TBS). [18F]fluorocholine PET/CT was performed in all patients for the detection and localization of parathyroid adenoma. Hyper- and normocalcemic patients were compared with regard to the proportion of osteoporosis and osteopenia, T-Score, TBS, serum calcium, phosphorus and parathyroid hormone levels, the maximum standardized uptake value (SUVmax) in PET/CT imaging, and laboratory results. Results: The majority of patients was female (88.57%) and had a pathologic bone mineral density (52.86%). Overall, 33 patients had osteoporosis and 41 osteopenia. The mean lumbar T-Score was -1.48 (SD 1.37) and the T-Score of the femoral neck was -1.21 (SD 0.92). Mean TBS was also decreased (-2.13). No difference was found between normo- or hypercalcemic patients regarding bone metabolism and imaging parameters. Conclusions: More than half of patients with normo- or hypercalcemic PHPT showed abnormal BMD. First-line [18F]fluorocholine PET/CT identified parathyroid adenoma in a high proportion of patients, even in patients with normocalcemic PHPT. The early evaluation of metabolic bone disease seems desirable in clinical management of females with PHPT.Objectives: Primary hyperparathyroidism (PHPT) is associated with normal or elevated calcium levels and affects bone mineral density. The proportion of cases predisposed to metabolic bone disease is unknown in patients with PHPT. The aim of this study was to assess bone mineral density and bone quality in patients with normo- or hypercalcemic primary hyperparathyroidism undergoing baseline parathyroid gland assessment with [18F]fluorocholine PET/CT imaging. Methods: A total of 140 consecutive patients were enrolled in this observational study. All patients with normo- or hypercalcemic primary hyperparathyroidism underwent dual-energy X-ray absorptiometry (DXA) for assessment of bone mineral density (BMD) and trabecular bone score (TBS). [18F]fluorocholine PET/CT was performed in all patients for the detection and localization of parathyroid adenoma. Hyper- and normocalcemic patients were compared with regard to the proportion of osteoporosis and osteopenia, T-Score, TBS, serum calcium, phosphorus and parathyroid hormone levels, the maximum standardized uptake value (SUVmax) in PET/CT imaging, and laboratory results. Results: The majority of patients was female (88.57%) and had a pathologic bone mineral density (52.86%). Overall, 33 patients had osteoporosis and 41 osteopenia. The mean lumbar T-Score was -1.48 (SD 1.37) and the T-Score of the femoral neck was -1.21 (SD 0.92). Mean TBS was also decreased (-2.13). No difference was found between normo- or hypercalcemic patients regarding bone metabolism and imaging parameters. Conclusions: More than half of patients with normo- or hypercalcemic PHPT showed abnormal BMD. First-line [18F]fluorocholine PET/CT identified parathyroid adenoma in a high proportion of patients, even in patients with normocalcemic PHPT. The early evaluation of metabolic bone disease seems desirable in clinical management of females with PHPT.</description><identifier>ISSN: 2075-4418</identifier><identifier>EISSN: 2075-4418</identifier><identifier>DOI: 10.3390/diagnostics14222466</identifier><language>eng</language><ispartof>Diagnostics (Basel), 2024-11, Vol.14 (22)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902,36990</link.rule.ids></links><search><creatorcontrib>Schaffler-Schaden, Dagmar</creatorcontrib><creatorcontrib>Schweighofer-Zwink, Gregor</creatorcontrib><creatorcontrib>Hehenwarter, Lukas</creatorcontrib><creatorcontrib>van der Zee-Neuen, Antje</creatorcontrib><creatorcontrib>Flamm, Maria</creatorcontrib><creatorcontrib>Beheshti, Mohsen</creatorcontrib><creatorcontrib>Pirich, Christian</creatorcontrib><title>Bone Mineral Density and First Line Imaging with 18Ffluorocholine PET/CT in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism: Results from a Single Center</title><title>Diagnostics (Basel)</title><description>Objectives: Primary hyperparathyroidism (PHPT) is associated with normal or elevated calcium levels and affects bone mineral density. The proportion of cases predisposed to metabolic bone disease is unknown in patients with PHPT. The aim of this study was to assess bone mineral density and bone quality in patients with normo- or hypercalcemic primary hyperparathyroidism undergoing baseline parathyroid gland assessment with [18F]fluorocholine PET/CT imaging. Methods: A total of 140 consecutive patients were enrolled in this observational study. All patients with normo- or hypercalcemic primary hyperparathyroidism underwent dual-energy X-ray absorptiometry (DXA) for assessment of bone mineral density (BMD) and trabecular bone score (TBS). [18F]fluorocholine PET/CT was performed in all patients for the detection and localization of parathyroid adenoma. Hyper- and normocalcemic patients were compared with regard to the proportion of osteoporosis and osteopenia, T-Score, TBS, serum calcium, phosphorus and parathyroid hormone levels, the maximum standardized uptake value (SUVmax) in PET/CT imaging, and laboratory results. Results: The majority of patients was female (88.57%) and had a pathologic bone mineral density (52.86%). Overall, 33 patients had osteoporosis and 41 osteopenia. The mean lumbar T-Score was -1.48 (SD 1.37) and the T-Score of the femoral neck was -1.21 (SD 0.92). Mean TBS was also decreased (-2.13). No difference was found between normo- or hypercalcemic patients regarding bone metabolism and imaging parameters. Conclusions: More than half of patients with normo- or hypercalcemic PHPT showed abnormal BMD. First-line [18F]fluorocholine PET/CT identified parathyroid adenoma in a high proportion of patients, even in patients with normocalcemic PHPT. The early evaluation of metabolic bone disease seems desirable in clinical management of females with PHPT.Objectives: Primary hyperparathyroidism (PHPT) is associated with normal or elevated calcium levels and affects bone mineral density. The proportion of cases predisposed to metabolic bone disease is unknown in patients with PHPT. The aim of this study was to assess bone mineral density and bone quality in patients with normo- or hypercalcemic primary hyperparathyroidism undergoing baseline parathyroid gland assessment with [18F]fluorocholine PET/CT imaging. Methods: A total of 140 consecutive patients were enrolled in this observational study. All patients with normo- or hypercalcemic primary hyperparathyroidism underwent dual-energy X-ray absorptiometry (DXA) for assessment of bone mineral density (BMD) and trabecular bone score (TBS). [18F]fluorocholine PET/CT was performed in all patients for the detection and localization of parathyroid adenoma. Hyper- and normocalcemic patients were compared with regard to the proportion of osteoporosis and osteopenia, T-Score, TBS, serum calcium, phosphorus and parathyroid hormone levels, the maximum standardized uptake value (SUVmax) in PET/CT imaging, and laboratory results. Results: The majority of patients was female (88.57%) and had a pathologic bone mineral density (52.86%). Overall, 33 patients had osteoporosis and 41 osteopenia. The mean lumbar T-Score was -1.48 (SD 1.37) and the T-Score of the femoral neck was -1.21 (SD 0.92). Mean TBS was also decreased (-2.13). No difference was found between normo- or hypercalcemic patients regarding bone metabolism and imaging parameters. Conclusions: More than half of patients with normo- or hypercalcemic PHPT showed abnormal BMD. First-line [18F]fluorocholine PET/CT identified parathyroid adenoma in a high proportion of patients, even in patients with normocalcemic PHPT. The early evaluation of metabolic bone disease seems desirable in clinical management of females with PHPT.</description><issn>2075-4418</issn><issn>2075-4418</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqVTU1Lw0AUXETBov0FXt7RS202u62pR2tDBZWiuZcleW2e7Efdt0Hyg_yfrR-IV-cyw8wwI8SFzK6UmmXjhszWB05Us9R5nuvp9EgM8ux6MtJaFsd_9KkYMr9mB8ykKvLJQHzcBo_wSB6jsXCHnin1YHwDJUVO8HBI4N6ZLfktvFNqQRblxnYhhroN9jNdLarxvALy8BSiC7WxNTqqv0aW_Q7jr7OK5Ezsv92diSa1fQzUELsbeEbubGLYxODAwMvh0CLM0SeM5-JkYyzj8IfPxGW5qObL0S6Gtw45rR1xjdYaj6HjtZJKaan1VKp_VPcH92tR</recordid><startdate>20241105</startdate><enddate>20241105</enddate><creator>Schaffler-Schaden, Dagmar</creator><creator>Schweighofer-Zwink, Gregor</creator><creator>Hehenwarter, Lukas</creator><creator>van der Zee-Neuen, Antje</creator><creator>Flamm, Maria</creator><creator>Beheshti, Mohsen</creator><creator>Pirich, Christian</creator><scope>7X8</scope></search><sort><creationdate>20241105</creationdate><title>Bone Mineral Density and First Line Imaging with 18Ffluorocholine PET/CT in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism: Results from a Single Center</title><author>Schaffler-Schaden, Dagmar ; Schweighofer-Zwink, Gregor ; Hehenwarter, Lukas ; van der Zee-Neuen, Antje ; Flamm, Maria ; Beheshti, Mohsen ; Pirich, Christian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_31334144613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schaffler-Schaden, Dagmar</creatorcontrib><creatorcontrib>Schweighofer-Zwink, Gregor</creatorcontrib><creatorcontrib>Hehenwarter, Lukas</creatorcontrib><creatorcontrib>van der Zee-Neuen, Antje</creatorcontrib><creatorcontrib>Flamm, Maria</creatorcontrib><creatorcontrib>Beheshti, Mohsen</creatorcontrib><creatorcontrib>Pirich, Christian</creatorcontrib><collection>MEDLINE - Academic</collection><jtitle>Diagnostics (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schaffler-Schaden, Dagmar</au><au>Schweighofer-Zwink, Gregor</au><au>Hehenwarter, Lukas</au><au>van der Zee-Neuen, Antje</au><au>Flamm, Maria</au><au>Beheshti, Mohsen</au><au>Pirich, Christian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bone Mineral Density and First Line Imaging with 18Ffluorocholine PET/CT in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism: Results from a Single Center</atitle><jtitle>Diagnostics (Basel)</jtitle><date>2024-11-05</date><risdate>2024</risdate><volume>14</volume><issue>22</issue><issn>2075-4418</issn><eissn>2075-4418</eissn><abstract>Objectives: Primary hyperparathyroidism (PHPT) is associated with normal or elevated calcium levels and affects bone mineral density. The proportion of cases predisposed to metabolic bone disease is unknown in patients with PHPT. The aim of this study was to assess bone mineral density and bone quality in patients with normo- or hypercalcemic primary hyperparathyroidism undergoing baseline parathyroid gland assessment with [18F]fluorocholine PET/CT imaging. Methods: A total of 140 consecutive patients were enrolled in this observational study. All patients with normo- or hypercalcemic primary hyperparathyroidism underwent dual-energy X-ray absorptiometry (DXA) for assessment of bone mineral density (BMD) and trabecular bone score (TBS). [18F]fluorocholine PET/CT was performed in all patients for the detection and localization of parathyroid adenoma. Hyper- and normocalcemic patients were compared with regard to the proportion of osteoporosis and osteopenia, T-Score, TBS, serum calcium, phosphorus and parathyroid hormone levels, the maximum standardized uptake value (SUVmax) in PET/CT imaging, and laboratory results. Results: The majority of patients was female (88.57%) and had a pathologic bone mineral density (52.86%). Overall, 33 patients had osteoporosis and 41 osteopenia. The mean lumbar T-Score was -1.48 (SD 1.37) and the T-Score of the femoral neck was -1.21 (SD 0.92). Mean TBS was also decreased (-2.13). No difference was found between normo- or hypercalcemic patients regarding bone metabolism and imaging parameters. Conclusions: More than half of patients with normo- or hypercalcemic PHPT showed abnormal BMD. First-line [18F]fluorocholine PET/CT identified parathyroid adenoma in a high proportion of patients, even in patients with normocalcemic PHPT. The early evaluation of metabolic bone disease seems desirable in clinical management of females with PHPT.Objectives: Primary hyperparathyroidism (PHPT) is associated with normal or elevated calcium levels and affects bone mineral density. The proportion of cases predisposed to metabolic bone disease is unknown in patients with PHPT. The aim of this study was to assess bone mineral density and bone quality in patients with normo- or hypercalcemic primary hyperparathyroidism undergoing baseline parathyroid gland assessment with [18F]fluorocholine PET/CT imaging. Methods: A total of 140 consecutive patients were enrolled in this observational study. All patients with normo- or hypercalcemic primary hyperparathyroidism underwent dual-energy X-ray absorptiometry (DXA) for assessment of bone mineral density (BMD) and trabecular bone score (TBS). [18F]fluorocholine PET/CT was performed in all patients for the detection and localization of parathyroid adenoma. Hyper- and normocalcemic patients were compared with regard to the proportion of osteoporosis and osteopenia, T-Score, TBS, serum calcium, phosphorus and parathyroid hormone levels, the maximum standardized uptake value (SUVmax) in PET/CT imaging, and laboratory results. Results: The majority of patients was female (88.57%) and had a pathologic bone mineral density (52.86%). Overall, 33 patients had osteoporosis and 41 osteopenia. The mean lumbar T-Score was -1.48 (SD 1.37) and the T-Score of the femoral neck was -1.21 (SD 0.92). Mean TBS was also decreased (-2.13). No difference was found between normo- or hypercalcemic patients regarding bone metabolism and imaging parameters. Conclusions: More than half of patients with normo- or hypercalcemic PHPT showed abnormal BMD. First-line [18F]fluorocholine PET/CT identified parathyroid adenoma in a high proportion of patients, even in patients with normocalcemic PHPT. The early evaluation of metabolic bone disease seems desirable in clinical management of females with PHPT.</abstract><doi>10.3390/diagnostics14222466</doi></addata></record>
fulltext fulltext
identifier ISSN: 2075-4418
ispartof Diagnostics (Basel), 2024-11, Vol.14 (22)
issn 2075-4418
2075-4418
language eng
recordid cdi_proquest_miscellaneous_3133414461
source Publicly Available Content Database; PubMed Central
title Bone Mineral Density and First Line Imaging with 18Ffluorocholine PET/CT in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism: Results from a Single Center
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T02%3A56%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bone%20Mineral%20Density%20and%20First%20Line%20Imaging%20with%2018Ffluorocholine%20PET/CT%20in%20Normocalcemic%20and%20Hypercalcemic%20Primary%20Hyperparathyroidism:%20Results%20from%20a%20Single%20Center&rft.jtitle=Diagnostics%20(Basel)&rft.au=Schaffler-Schaden,%20Dagmar&rft.date=2024-11-05&rft.volume=14&rft.issue=22&rft.issn=2075-4418&rft.eissn=2075-4418&rft_id=info:doi/10.3390/diagnostics14222466&rft_dat=%3Cproquest%3E3133414461%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_miscellaneous_31334144613%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3133414461&rft_id=info:pmid/&rfr_iscdi=true